These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29523760)

  • 41. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipopolysaccharide induced the proliferation of mouse lung fibroblasts by suppressing FoxO3a/p27 pathway.
    Gu N; Xing S; Chen S; Zhou Y; Jiang T; Jiao Y; Gao Y; Yu W; He Z; Wen D
    Cell Biol Int; 2018 Sep; 42(10):1311-1320. PubMed ID: 29907991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
    Wu W; Zou M; Brickley DR; Pew T; Conzen SD
    Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proliferation of murine c-kit(pos) cardiac stem cells stimulated with IGF-1 is associated with Akt-1 mediated phosphorylation and nuclear export of FoxO3a and its effect on downstream cell cycle regulators.
    Johnson AM; Kartha CC
    Growth Factors; 2014 Apr; 32(2):53-62. PubMed ID: 24580070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.
    Kim S; Lee E; Jung J; Lee JW; Kim HJ; Kim J; Yoo HJ; Lee HJ; Chae SY; Jeon SM; Son BH; Gong G; Sharan SK; Chang S
    Oncogene; 2018 May; 37(22):2982-2991. PubMed ID: 29527004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling.
    Zhao GX; Xu LH; Pan H; Lin QR; Huang MY; Cai JY; Ouyang DY; He XH
    Oncotarget; 2015 Nov; 6(36):38952-66. PubMed ID: 26517515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
    Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
    Eddy SF; Kane SE; Sonenshein GE
    Cancer Res; 2007 Oct; 67(19):9018-23. PubMed ID: 17909003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].
    Gong XD; Yuan HH; Wang JY; Guo YH; Shi J; Jiang B
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):572-8. PubMed ID: 24314213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review.
    Taylor S; Lam M; Pararasa C; Brown JE; Carmichael AR; Griffiths HR
    Cancer Cell Int; 2015; 15(1):1. PubMed ID: 25678856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role and regulation of FOXO3a: new insights into breast cancer therapy.
    Mei W; Mei B; Chang J; Liu Y; Zhou Y; Zhu N; Hu M
    Front Pharmacol; 2024; 15():1346745. PubMed ID: 38505423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evidence for repurposing anti-epileptic drugs to target cancer.
    Aroosa M; Malik JA; Ahmed S; Bender O; Ahemad N; Anwar S
    Mol Biol Rep; 2023 Sep; 50(9):7667-7680. PubMed ID: 37418080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concerns about lamotrigine.
    Husein N; Thijs RD; Bunschoten JW; Keezer MR; Sander JW
    Lancet Neurol; 2021 Jun; 20(6):418-419. PubMed ID: 34022162
    [No Abstract]   [Full Text] [Related]  

  • 55. Foxo3a re-expression overcomes tamoxifen resistance in breast cancer.
    ; Morelli C; Fiorillo M; Pellegrino M; Rizza P; Nigro A; Ricci E; Lanzino M; Sisci D
    J Biol Regul Homeost Agents; 2018; 32(4 Suppl. 1):43. PubMed ID: 30810021
    [No Abstract]   [Full Text] [Related]  

  • 56. Correction: Qian et al. Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways.
    Qian K; Wang G; Cao R; Liu T; Qian G; Guan X; Guo Z; Xiao Y; Wang X
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
    Kong W; He L; Coppola M; Guo J; Esposito NN; Coppola D; Cheng JQ
    J Biol Chem; 2016 Oct; 291(43):22855. PubMed ID: 27825093
    [No Abstract]   [Full Text] [Related]  

  • 58. FOXO3a: A Potential Target in Prostate Cancer.
    Shukla S
    Austin J Urol; 2014; 1(1):. PubMed ID: 25584362
    [No Abstract]   [Full Text] [Related]  

  • 59. FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer.
    Pellegrino M; Rizza P; Donà A; Nigro A; Ricci E; Fiorillo M; Perrotta I; Lanzino M; Giordano C; Bonofiglio D; Bruno R; Sotgia F; Lisanti MP; Sisci D; Morelli C
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31769419
    [No Abstract]   [Full Text] [Related]  

  • 60. Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case-control study.
    Li DJ; Tsai SJ; Chen TJ; Liang CS; Chen MH
    Eur Arch Psychiatry Clin Neurosci; 2024 Mar; ():. PubMed ID: 38554178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.